Cite
HARVARD Citation
Haghikia, A. et al. (n.d.). Severe B-cell-mediated CNS disease secondary to alemtuzumab therapy. Lancet neurology. 16 (2), pp. 104-106. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Haghikia, A. et al. (n.d.). Severe B-cell-mediated CNS disease secondary to alemtuzumab therapy. Lancet neurology. 16 (2), pp. 104-106. [Online].